Therefore, we hypothesize that SFN may reduce mitochondrial oxidative stress levels and improve skeletal muscles function in sarcopenia through activation of the AMPK/Sirt1/PGC-1α/Nrf2 signaling pathway. This evidence concerns the gene PPARGC1A and sarcopenia.